Diverse Clinical Effects of SGLT2 Inhibitor: Case Presentation and Literature Mini-review-Reference-Cited by-同舟云学术

Diverse Clinical Effects of SGLT2 Inhibitor: Case Presentation and Literature Mini-review

Published:2023-09-10 Issue:9 Volume:49 Page:321-330
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

Author:

Aso Yukio¹,Kataoka Hajime²,Harada Saki¹,Yamasaki Yu¹,Sugata Tetsuji¹

Affiliation:

1. Department of Pharmacy, Medical Corporation Jikeikai Nishida Hospital

2. Department of Internal Medicine, Medical Corporation Jikeikai Nishida Hospital

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Link

https://www.jstage.jst.go.jp/article/jjphcs/49/9/49_321/_pdf

Reference35 articles.

1. 1）Ghosh RK, Ghosh SM, Chawla S, Jasdanwala SA, SGLT2 inhibitors: A new emerging therapeutic class in the treatment of type 2 diabetes mellitus, J Clinical Pharmacol, 2012, 52, 457-463.

2. 2）Lopaschuk GD, Verma S, Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors, JACC Basic Trans Science, 2020, 5, 632-644.

3. 3）Kataoka H, Effects of SGLT2 inhibitor on neurohormonal activity and electrolyte management in an elderly patient with type 2 diabetes mellitus and acute heart failure: A case report, Ann Cardiol Vasc Med, 2020, 3, 1038.

4. 4）Kataoka H, Yoshida Y, Enhancement of the serum chloride concentration by administration of sodium–glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: A pilot study, Diabetol Metab Syndr, 2020, 12, 5. doi : 10.1186/s13098-020-0515-x.

5. 5）Kataoka H, Favorable effect of sodium-glucose cotransporter-2 inhibitor on respiratory function in type 2 diabetic patients, J Endocrine Dis & Ther, 2020, 1, 5-9.